In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Compass Pathways Plc ADR (NASDAQ: CMPS) was $5.31 for the day, down -2.57% from the previous closing price of $5.45. In other words, the price has decreased by -$2.57 from its previous closing price. On the day, 0.96 million shares were traded. CMPS stock price reached its highest trading level at $5.56 during the session, while it also had its lowest trading level at $5.17.
Ratios:
Our analysis of CMPS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.91 and its Current Ratio is at 8.91. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on July 23, 2024, initiated with a Outperform rating and assigned the stock a target price of $23.
On April 01, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $30.
On December 12, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $16.Deutsche Bank initiated its Buy rating on December 12, 2023, with a $16 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 26 ’24 when ATAI Life Sciences N.V. sold 2,660,000 shares for $6.05 per share. The transaction valued at 16,093,000 led to the insider holds 6,905,774 shares of the business.
Malievskaia Ekaterina sold 8,900 shares of CMPS for $70,379 on May 21 ’24. The 10% Owner now owns 3,931,687 shares after completing the transaction at $7.91 per share. On May 21 ’24, another insider, Malievskaia Ekaterina, who serves as the 10% Owner of the company, sold 8,900 shares for $7.91 each. As a result, the insider received 70,379 and left with 3,929,413 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMPS now has a Market Capitalization of 363314432 and an Enterprise Value of 198493456.
Stock Price History:
Over the past 52 weeks, CMPS has reached a high of $12.75, while it has fallen to a 52-week low of $4.05. The 50-Day Moving Average of the stock is -15.44%, while the 200-Day Moving Average is calculated to be -32.52%.
Shares Statistics:
CMPS traded an average of 744.35K shares per day over the past three months and 1867690 shares per day over the past ten days. A total of 68.41M shares are outstanding, with a floating share count of 62.66M. Insiders hold about 8.40% of the company’s shares, while institutions hold 33.28% stake in the company. Shares short for CMPS as of 1728950400 were 5807649 with a Short Ratio of 7.80, compared to 1726185600 on 5869153. Therefore, it implies a Short% of Shares Outstanding of 5807649 and a Short% of Float of 10.15.
